Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Lavandula angustifolia (Linalool).
Lavandula angustifolia exerts potent anxiolytic and sedative effects primarily through the modulation of GABA-A receptors and inhibition of voltage-gated calcium channels by its primary monoterpene constituents.
6549
154.25 g/mol
2.7
3,7-dimethylocta-1,6-dien-3-ol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Lavandula angustifolia (Linalool) across standard consumer modalities.
The high volatility and oxidative sensitivity of linalool necessitate specialized hermetic sealing or nitrogen flushing to prevent degradation within hard-shell capsules.
The hydrophobic nature of lavender essential oil requires robust emulsification to prevent phase separation and 'blooming' during the pectin gelation process.
The significant dosage required for clinical efficacy often exceeds the 50mg payload limit of standard thin-film polymer matrices, leading to structural brittleness.
Ready to launch a product featuring Lavandula angustifolia (Linalool)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Lavandula angustifolia (Linalool) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Lavandula angustifolia (Linalool) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation